Evidence map›Paper›PMID 40990140›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2025

Real-Time, Noninvasive Diagnosis of Bullous Pemphigoid: Diagnostic Performance of Line-Field Confocal Optical Coherence Tomography.

Frank Friedrich Gellrich, Samal Rakhmetova, Claudia Günther, Stefan Beissert, Sarah Hobelsberger

Abstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Emerging Paediatric Uses of Dupilumab Beyond Approvals.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Review
  2. Article
  3. Real-Time, Noninvasive Diagnosis of Bullous Pemphigoid: Diagnostic Performance of Line-Field Confocal Optical Coherence Tomography.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Frank Friedrich GellrichDepartment of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0002-2164-4644
Samal RakhmetovaDepartment of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Claudia GüntherDepartment of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0002-4330-1861
Stefan BeissertDepartment of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0002-8327-8475
Sarah HobelsbergerDepartment of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0001-5703-324X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBullous pemphigoid (BP) is a common autoimmune blistering dermatosis often difficult to distinguish from other inflammatory conditions. Timely diagnosis is crucial for appropriate management. Line-field confocal optical coherence tomography (LC-OCT), a noninvasive imaging technique that uses an 800nm laser to generate high-resolution vertical and horizontal cross-sectional images of the skin, is evaluated as a diagnostic tool for BP. MATERIALS AND

methodsA prospective, single-center study was conducted on 26 patients with suspected BP. LC-OCT imaging, histopathology, and direct immunofluorescence (DIF) were performed. LC-OCT images were assessed for the presence of key diagnostic features, including subepidermal cleavage and eczema criteria.

resultsBased on histopathology, DIF, indirect immunofluorescence (IIF), and ELISA, the final diagnoses were 15 BP cases and 11 non-BP cases. LC-OCT correctly identified 12 of 15 BP cases and all 11 non-BP cases, demonstrating a sensitivity of 0.8 and a specificity of 1.0. The presence of subepidermal cleavage was a key diagnostic criterion for BP (p = 0.000). The absence of alternating hypo- and hyper-reflective layers (p = 0.000), thickened and disrupted stratum corneum (p = 0.014), spongiosis (p = 0.036), and thickened epidermis (p = 0.043), which occurred significantly less frequently in BP cases, further supported the diagnosis.

conclusionLC-OCT demonstrates high sensitivity and specificity in diagnosing BP, offering a rapid, point-of-care diagnostic approach. LC-OCT can be used to evaluate unclear inflammatory skin conditions and guide further investigations. However, LC-OCT has limitations in diagnosing non-bullous stages of BP; thus, histology and DIF remain the gold standard for definitive diagnosis.

Indexed as

Pemphigoid, BullousTomography, Optical CoherenceAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedProspective StudiesSensitivity and SpecificitySkinautoimmune blistering diseasebullous pemphigoideczemaline‐field confocal optical coherence tomographynon‐invasive diagnosisreal‐time imaging

Identifiers

PMID40990140
PMCPMC12457975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.